RETACRIT 8 000 IU/0.8 ml, solution for injection in a pre-filled syringe 6 syringes of 0.8 ml
Active ingredients: ÉPOÉTINE ZÊTA
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection6 syringes of 0.8 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RETACRIT 8 000 UI/0,8 mL, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 6 seringue(s) préremplie(s) en verre de 0,8 ml avec dispositif(s) de sécurité de l'aiguille
- Marketing authorisation holder
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 May 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63722806CIP73001215CIP133400930012154Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉPOÉTINE ZÊTAsolution | 8000 UI · une seringue préremplie de 0,8 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.